London, January 11th, 2024 – Permira, the global private equity firm, today announced the appointment of seasoned healthcare executive, Jon Serbousek, as a Senior Adviser to its global Healthcare team.
Jon brings an extensive track record to Permira, with more than 35 years of experience in the healthcare sector. His career includes international leadership roles in leading medical technology companies, notably Nasdaq-listed Orthofix Medical, Biomet, Medtronic and DePuy Orthopedics, a Johnson and Johnson company, contributing significantly to the medical device and biologics fields.
In his most recent position, Jon led Orthofix Medical as its President, CEO and Director, and until recently as Executive Chairman of the newly merged Orthofix-SeaSpine. His prior roles include, Worldwide Group President of Biomet Orthopedics, Worldwide President of Biomet Biologics, Division President for Medtronic Spine and Biologics, and Vice President of Marketing and Product Development for DePuy Orthopedics, a Johnson & Johnson company.
Jon holds a B.S in Engineering from Washington State University and a M.S. in Bioengineering from the University of Utah, in addition to advanced management programs at the IMD International School of Management in Lausanne, Switzerland. In addition to his extensive operational experience, Jon has served on numerous boards, both for-profit and not-for-profit, bringing valuable insights and strategic leadership to multiple organizations.
Silvia Oteri, Partner and Head of Healthcare at Permira, said: “We are thrilled to welcome Jon to our team. His broad experience, strategic acumen, and deep knowledge of the MedTech space will be invaluable as we continue to build and expand our investments in the healthcare sector."
Jon Serbousek, Senior Advisor at Permira, said: "I'm excited to join Permira, a firm known for its deep understanding of healthcare and commitment to long-term value creation. I look forward to leveraging my experience to support the healthcare team and help drive growth and innovation for Permira's portfolio companies and stakeholders."
As a Senior Adviser, Jon will partner with investment teams to identify new opportunities and help management teams to drive value for portfolio companies. Permira remains an active investor in the Healthcare sector, with investments in approximately 20 companies globally, deploying over €4 billion. Permira’s Senior Advisers partner with investment teams to identify new opportunities and help management teams drive value through scaling champions globally.
